Trade/Project Financier, Bachmann & Welser To Launch USD 2 billion Project Finance Fund

EDINBURGH, Scotland, February 17, 2018 — Global Trade/Project Financier, Bachmann & Welser will launch a USD 2 billion Project finance fund in March 2018 with funds that will be backed by several... Read more »

New Data in Pediatric Patients with Axillary Hyperhidrosis Presented During Late-Breaking Research Forum at the 76th Annual Meeting of the American Academy of Dermatology

SAN DIEGO, Feb. 17, 2018 — Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with... Read more »

AbbVie Presents New Positive Late-Breaking Data from Two Phase 3 Psoriasis Trials of Risankizumab at the 2018 American Academy of Dermatology Annual Meeting

NORTH CHICAGO, Ill., Feb. 17, 2018 — AbbVie (NYSE: ABBV), a global research and development-based biopharmaceutical company, today presented new positive results from the pivotal Phase 3 ultIMMa-1 and ultIMMa-2 replicate clinical... Read more »

AnaptysBio Presents Updated Data from ANB020 Phase 2a Atopic Dermatitis Trial at AAD Annual Meeting

SAN DIEGO, Feb. 17, 2018 — AnaptysBio, Inc. (Nasdaq:ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced that updated data from the... Read more »

TiENPAY Limited Announces Expansion Into South Korea With New Joint Venture

Press Release – updated: Feb 18, 2018 05:09 SGT HONG KONG, February 18, 2018 – TiENPAY Limited announced their new subsidiary by means of a Joint Venture: TiENPAY Korea Co., Limited. TiENPAY Korea will... Read more »

AbbVie Presents New Late-Breaking Phase 2b Data on Upadacitinib in Atopic Dermatitis at the 2018 American Academy of Dermatology Annual Meeting

NORTH CHICAGO, Ill., Feb. 17, 2018 – AbbVie (NYSE: ABBV), a global research and development-based biopharmaceutical company, today presented new positive results from a Phase 2b dose-ranging study evaluating upadacitinib, an investigational, once-daily... Read more »

Targa Resources Corp. and Targa Resources Partners Announce Form 10-Ks Available

HOUSTON, Feb. 17, 2018 — Targa Resources Corp. (NYSE:TRGP) (“TRC” or the “Company”) and Targa Resources Partners LP (“Targa Resources Partners” or the “Partnership”) have filed their respective Form 10-Ks with the... Read more »

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MetLife, Inc. of Class Action Lawsuit and Upcoming Deadline – MET

NEW YORK, Feb. 17, 2018 — Pomerantz LLP announces that a class action lawsuit has been filed against MetLife, Inc. (“MetLife” or the “Company”) (NYSE:  MET) and certain of its officers.   The... Read more »

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro Incorporated of Class Action Lawsuit and Upcoming Deadline – TSRO

NEW YORK, Feb. 17, 2018 — Pomerantz LLP announces that a class action lawsuit has been filed against Tesaro Incorporated (“Tesaro” or the “Company”) (NASDAQ:  TSRO) and certain of its officers.   The... Read more »

ImmVRse Collaborates With Imperial College to Lead Research on Impact of VR on Neural Activity

ImmVRse will be working with a group of bright medical students to study 'The Impact of Virtual Reality on Neural Activity' Press Release – updated: Feb 17, 2018 16:48 EST LONDON, February... Read more »